Koers Green and Hill Industries, Inc Other OTC
Aandelen
GHIL
US39260U1060
Farmaceutische producten
Omzet 2013 | - | Omzet 2014 | 0 0 | Marktkapitalisatie | 103 94,76 |
---|---|---|---|---|---|
Nettowinst (verlies) 2013 | - 0 | Nettowinst (verlies) 2014 | - 0 | EV/omzet 2013 * | - |
Nettoliquiditeiten 2013 * | - 0 | Nettoliquiditeiten 2014 * | - 0 | EV/omzet 2014 * | - |
K/w-verhouding 2013 * |
-
| K/w-verhouding 2014 * |
-
| Werknemers | - |
Dividendrendement 2013 * |
-
| Dividendrendement 2014 * |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ross Rebagliati
CEO | Chief Executive Officer | - | 17-03-14 |
Patrick Smyth
PSD | President | - | 17-03-14 |
Lorne Green
SEC | Corporate Secretary | - | 12-01-13 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Patrick Smyth
PSD | President | - | 17-03-14 |
Lorne Green
SEC | Corporate Secretary | - | 12-01-13 |
Ross Rebagliati
CEO | Chief Executive Officer | - | 17-03-14 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+42,64% | 6,38 mld. | |
-15,52% | 4,59 mld. | |
+8,35% | 3,39 mld. | |
-11,10% | 3,2 mld. | |
-4,12% | 2,52 mld. | |
+46,46% | 2 mld. | |
-7,97% | 1,7 mld. | |
-1,07% | 1,65 mld. | |
-11,56% | 1,58 mld. |